Accurate cut-offs for predicting endoscopic activity and mucosal healing in Crohn’s disease with fecal calprotectin

Vázquez-Morón, Juan María; Pallarés-Manrique, Héctor; Machancoses, Francisco H; Ramos-Lora, Manuel; Ruiz-Frutos, Carlos.
Rev. esp. enferm. dig ; 109(2): 130-136, feb. 2017. tab, ilus
Artículo en Inglés | IBECS (España) | ID: ibc-159856

Documentos relacionados

  1. Ultrasonographic Transmural Healing in Crohn's Disease.
  2. Transmural or mucosal healing in Crohn´s disease. Which is the goal to be pursued?
  3. Epigenetic reader SP140 loss of function drives Crohn's disease due to uncontrolled macrophage topoisomerases.
  4. Gut vascular barrier in the pathogenesis and resolution of Crohn's disease: A novel link from origination to therapy.
  5. Combination of serological biomarkers and clinical features to predict mucosal healing in Crohn's disease: a multicenter cohort study.
  6. Induction Efficacy of Upadacitinib in Therapy-Refractory Crohn's Disease: A Retrospective Case Series.
  7. Intestinal ultrasound score predicts therapeutic outcomes of infliximab in pediatric patients with Crohn's disease.
  8. Clinical outcomes in pediatric inflammatory bowel disease patients: a systematic review of prospective studies.
  9. Role of fecal calprotection in predicting endoscopic recurrence in postoperative Crohn's disease.
  10. In active Crohn disease, risankizumab increased clinical remission and endoscopic response at 12 wk.